Home › Funds › Foresite Capital Management V, LLC › EIKN

Foresite Capital Management V, LLC position in EIKN

EIKON THERAPEUTICS INC · Health Care

Foresite Capital Management V, LLC reported holding 1,318,983 shares of EIKN (EIKON THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$17.2M, representing 4.75% of its reported portfolio and ranking #6 among its reported holdings. Foresite Capital Management V, LLC has disclosed EIKN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.32M sh
Reported value held$17.21M
Portfolio Weight4.75%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Foresite Capital Management V, LLC's EIKN position evolved

Foresite Capital Management V, LLC first disclosed a stake in EIKN in Q1 2026 at 1,318,983 shares (US$14.0M). The position peaked in Q2 2026 at 1,318,983 shares, worth US$17.2M. Across 2 filings, Foresite Capital Management V, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,318,983 shares valued at US$17.2M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.32M $13.95M New
Q2 2026 1.32M $17.21M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EIKN and 13F data

EIKN (EIKON THERAPEUTICS INC) is a Health Care company. 88 other funds we track also report a position in EIKN — the largest reported positions include Foresite Capital Management IV, LLC (US$25.4M), Merck & Co., Inc. (US$21.7M), EcoR1 Capital, LLC (US$9.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EIKN

All EIKN fund holders →

FAQ

How long has Foresite Capital Management V, LLC held EIKN?

Foresite Capital Management V, LLC has disclosed EIKN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Foresite Capital Management V, LLC's current position in EIKN?

As of Q2 2026, Foresite Capital Management V, LLC holds 1.32M shares of EIKN (EIKON THERAPEUTICS INC), valued at $17.21M, representing 4.75% of its reported portfolio and ranking #6.

Has Foresite Capital Management V, LLC been buying or selling EIKN?

In the latest 13F filing (Q2 2026), Foresite Capital Management V, LLC held unchanged its position in EIKN. The position peaked in Q2 2026 at 1.32M shares.

Which other funds hold EIKN?

Other major institutional holders of EIKN include Foresite Capital Management IV, LLC, Merck & Co., Inc., EcoR1 Capital, LLC, among 88 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.